Luned Badder
Impact in
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Bone health and treatments
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- DNA Repair Mechanisms 2
- Oncology 5
- CAR-T cell therapy research 3
- PARP inhibition in cancer therapy 2
- Co-authors
- Karl Morten (2 shared papers)Helen J. Knowles (1 shared paper)Eleanor Knight (2 shared papers)Rebecca Marlow (2 shared papers)Andrew Tutt (2 shared papers)Christopher J. Lord (2 shared papers)Jiří Bártek (1 shared paper)Yilun Sun (1 shared paper)
- Journals
- British Journal of Cancer (1 paper)Nature Cell Biology (1 paper)Advances in experimental medicine and biology (1 paper)Viruses (1 paper)Nature (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Luned Badder
7 papers receiving 296 citations
Peers
Comparison fields: 5 of 58
- Oncology 113
- Cancer Research 50
- Molecular Biology 221
- Cell Biology 52
- Developmental Neuroscience 8
Countries citing papers authored by Luned Badder
This map shows the geographic impact of Luned Badder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luned Badder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luned Badder more than expected).
Fields of papers citing papers by Luned Badder
This network shows the impact of papers produced by Luned Badder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luned Badder. The network helps show where Luned Badder may publish in the future.
Co-authors
The 25 scholars most cited alongside Luned Badder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 92 | |
| 2 | 2020 | 77 | |
| 3 | 2013 | 75 | |
| 4 | 2016 | 35 | |
| 5 | 2021 | 10 | |
| 6 | 2016 | 5 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 0 |
About Luned Badder
Luned Badder is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Cellular and Molecular Neuroscience, having authored 8 papers that have together received 297 indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), DNA Repair Mechanisms (2 papers), PARP inhibition in cancer therapy (2 papers), Nanoplatforms for cancer theranostics (1 paper), Neuroscience and Neural Engineering (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Oncology (113 citations), Cancer Research (50 citations), Molecular Biology (221 citations), Cell Biology (52 citations) and Developmental Neuroscience (8 citations). Luned Badder has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Karl Morten, Helen J. Knowles, Eleanor Knight, Rebecca Marlow, Andrew Tutt, Christopher J. Lord, Jiří Bártek, Yilun Sun, Yves Pommier and Lu Yu. Their work appears in journals such as British Journal of Cancer, Nature Cell Biology, Advances in experimental medicine and biology, Viruses and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.